Cost-Effectiveness of Point-of-Care HCV RNA Testing in US episode artwork

EPISODE · May 5, 2026 · 1 MIN

Cost-Effectiveness of Point-of-Care HCV RNA Testing in US

from TheBrief.Health · host TheBrief.Health

Hepatitis C virus (HCV) RNA testing at the point of care is emerging as a practical way to identify and treat people living with HCV more quickly. As direct-acting antiviral drugs make cure routine, the real bottleneck has shifted to identifying who is infected and getting them started on treatment without losing them between appointments.

Episode metadata supplied by the publisher feed · Published May 5, 2026

Embed this episode

NOW PLAYING

Cost-Effectiveness of Point-of-Care HCV RNA Testing in US

0:00 1:51

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of TheBrief.Health?

This episode is 1 minute long.

When was this TheBrief.Health episode published?

This episode was published on May 5, 2026.

Can I download this TheBrief.Health episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!